- Home
- ADVM vs SBI Comparison
ADVM vs SBI Comparison
Compare ADVM & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- SBI
- Stock Information
- Founded
- ADVM 2006
- SBI 1992
- Country
- ADVM United States
- SBI United States
- Employees
- ADVM N/A
- SBI N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- SBI Finance/Investors Services
- Sector
- ADVM Health Care
- SBI Finance
- Exchange
- ADVM Nasdaq
- SBI Nasdaq
- Market Cap
- ADVM 119.6M
- SBI 112.9M
- IPO Year
- ADVM 2014
- SBI N/A
- Fundamental
- Price
- ADVM $6.04
- SBI $8.02
- Analyst Decision
- ADVM Strong Buy
- SBI
- Analyst Count
- ADVM 6
- SBI 0
- Target Price
- ADVM $27.83
- SBI N/A
- AVG Volume (30 Days)
- ADVM 252.6K
- SBI 39.5K
- Earning Date
- ADVM 11-04-2024
- SBI 01-01-0001
- Dividend Yield
- ADVM N/A
- SBI 4.52%
- EPS Growth
- ADVM N/A
- SBI N/A
- EPS
- ADVM N/A
- SBI N/A
- Revenue
- ADVM $1,000,000.00
- SBI N/A
- Revenue This Year
- ADVM N/A
- SBI N/A
- Revenue Next Year
- ADVM $1,294.35
- SBI N/A
- P/E Ratio
- ADVM N/A
- SBI N/A
- Revenue Growth
- ADVM N/A
- SBI N/A
- 52 Week Low
- ADVM $5.69
- SBI $6.96
- 52 Week High
- ADVM $29.70
- SBI $8.00
- Technical
- Relative Strength Index (RSI)
- ADVM 31.12
- SBI 42.61
- Support Level
- ADVM $6.81
- SBI $8.01
- Resistance Level
- ADVM $7.73
- SBI $8.07
- Average True Range (ATR)
- ADVM 0.46
- SBI 0.06
- MACD
- ADVM -0.22
- SBI 0.00
- Stochastic Oscillator
- ADVM 14.06
- SBI 15.38
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About SBI Western Asset Intermediate Muni Fund Inc
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes.